Patient Choice Stressed in Latest USPSTF PSA Screening Recs

Share this content:
Patient Choice Stressed in Latest USPSTF PSA Screening Recs
Patient Choice Stressed in Latest USPSTF PSA Screening Recs

TUESDAY, April 11, 2017 (HealthDay News) -- The U.S. Preventive Services Task Force is recommending that men aged 55 to 69 have a discussion with their doctor about the pros and cons of prostate-specific antigen (PSA) screening for detecting prostate cancer.

The recommendation applies to men who have not been diagnosed with prostate cancer and have no signs or symptoms of the disease. In addition, the recommendation is for men at average risk and those at increased risk for prostate cancer, such as black men and men with a family history of prostate cancer. Men at increased risk for prostate cancer should take that into consideration when making the decision to be screened for PSA levels. For men aged 70 and older, the recommendation for no PSA screening remains in place.

"There is probably a small benefit overall to screening," Task Force chair Kirsten Bibbins-Domingo, M.D., Ph.D., a chair in medicine and a professor of medicine, epidemiology, and biostatistics at the University of California, San Francisco, told HealthDay. "But the right decision is not a one-size-fits-all decision. The right decision isn't screening all men, it's making all men aware of the benefits and harms, and then allowing each man to make the best decision for himself."

The draft recommendation was published on the Task Force's website on April 11, and it is open to public comment until May 8. After the comment period ends, the Task Force will consider the input and come up with its final recommendation in the following months.

Evidence Review
Draft Recommendation Statement
Comment on Recommendation

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »